These results are supported by previous evidence showing that higher CSF tau concentrations predict lower cerebral glucose metabolism, and that FDG hypometabolism acts as a mediator between CSF tau and cognitive impairment in MCI/AD [94]. The gene discussed is MAPT; the disease is Cognitive impairment.